Financials Transgene

Equities

Market Closed - Euronext Paris Other stock markets 10:25:00 13/03/2026 pm IST			5-day change	1st Jan Change
0.7800 ^EUR	0.00%		-4.88%	-18.75%

02/03	Certain Ordinary Shares of Transgene SA are subject to a Lock-Up Agreement Ending on 2-MAR-2026.	CI
25/02	Adocia SA Announces Board Changes	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	9.915	17.41	10.34	7.9	6.353	6.3	6.3	6.3
Change	-	75.62%	-40.6%	-23.63%	-19.58%	-0.83%	0%	0%
EBITDA ¹	-22.21	-21	-28.22	-28.48	-34.38	-35.1	-44.6	-71.1
Change	-	5.42%	-34.35%	-0.91%	-20.73%	-2.1%	-27.07%	-59.42%
EBIT ¹	-23.99	-23.52	-29.9	-30.05	-35.66	-35.7	-45.2	-71.7
Change	-	1.95%	-27.12%	-0.48%	-18.67%	-0.12%	-26.61%	-58.63%
Interest Paid ¹	-6.762	3.989	-0.804	7.719	1.687	-0.1	-0.2	-0.4
Earnings before Tax (EBT)	-17.23	-19.54	-32.8	-	-	-	-	-
Change	-	-13.38%	-67.92%	-	-	-	-	-
Net income ¹	-17.23	-19.54	-32.8	-22.33	-33.97	-31.2	-39.6	-62.9
Change	-	-13.38%	-67.92%	31.94%	-52.15%	8.16%	-26.92%	-58.84%
Announcement Date	10/03/21	16/03/22	16/03/23	27/03/24	27/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-7.99	-32.9	-13.3	1.63	-6.27	-70.9	-30.4	33.4
Change	-	-311.76%	59.57%	112.26%	-484.66%	-1,030.06%	57.12%	209.87%
Announcement Date	10/03/21	16/03/22	16/03/23	27/03/24	27/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	0.852	0.686	1.535	-	3.066	0.9	0.9	0.9
Change	-	-19.48%	123.76%	-	-	-70.65%	0%	0%
Free Cash Flow (FCF) ¹	-29.59	-32.61	-21.84	-0.099	-26.75	-32.4	-32.4	-55.6
Change	-	-10.2%	33.04%	99.55%	-26,924.24%	-21.1%	0%	-71.6%
Announcement Date	10/03/21	16/03/22	16/03/23	27/03/24	27/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-223.97%	-120.62%	-272.8%	-360.44%	-541.11%	-557.14%	-707.94%	-1,128.57%
EBIT Margin (%)	-241.99%	-135.1%	-289.1%	-380.34%	-561.28%	-566.67%	-717.46%	-1,138.1%
EBT Margin (%)	-173.79%	-112.19%	-317.13%	-	-	-	-	-
Net margin (%)	-173.79%	-112.19%	-317.13%	-282.63%	-534.72%	-495.24%	-628.57%	-998.41%
FCF margin (%)	-298.48%	-187.3%	-211.12%	-1.25%	-421.12%	-514.29%	-514.29%	-882.54%
FCF / Net Income (%)	171.75%	166.94%	66.57%	0.44%	78.76%	103.85%	81.82%	88.39%
Profitability
ROA	-	-	-	-	-	-	-	-
ROE	-29.72%	-33.13%	-62.45%	-	-	-59.8%	-57.1%	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-0.06x	-	-	-	-0.47x
Debt / Free cash flow	-	-	-	-16.45x	-	-	-	-0.6x
Capital Intensity
CAPEX / Current Assets (%)	8.59%	3.94%	14.84%	-	48.26%	14.29%	14.29%	14.29%
CAPEX / EBITDA (%)	-3.84%	-3.27%	-5.44%	-	-8.92%	-2.56%	-2.02%	-1.27%
CAPEX / FCF (%)	-2.88%	-2.1%	-7.03%	-	-11.46%	-2.78%	-2.78%	-1.62%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	0.6007	0.6887	0.3787	0.1553	0.1149	0.11	0.32	-0.05
Change	-	14.64%	-45.01%	-58.99%	-26.01%	-4.26%	190.91%	-115.62%
EPS ¹	-0.21	-0.21	-0.33	-0.22	-0.29	-0.11	-0.14	-0.23
Change	-	0%	-57.14%	33.33%	-31.82%	62.07%	-27.27%	-64.29%
Nbr of stocks (in thousands)	83,677	97,576	99,370	1,00,566	1,31,990	2,73,827	2,73,827	2,73,827
Announcement Date	10/03/21	16/03/22	16/03/23	27/03/24	27/03/25	-	-	-